Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: January 31, 2011 (Third Quarter of Fiscal Year 2011)
Business Overview: The Company manufactures laboratory furniture and equipment. It operates through Domestic and International segments. As of March 11, 2011, there were 2,578,270 shares of Common Stock outstanding.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Jan 31, 2011 | 9 Months Ended Jan 31, 2011 |
|---|---|---|
| Net Sales | $22,568 | $73,051 |
| Gross Profit | $4,163 | $14,579 |
| Gross Margin | 18.4% | 20.0% |
| Operating Earnings | $156 | $2,626 |
| Net Earnings (Attributable to Kewaunee) | $86 | $1,598 |
| Diluted EPS | $0.03 | $0.62 |
| Cash from Operations (9 Months) | $6,135 | |
| Capital Expenditures (9 Months) | ($4,698) | |
| Working Capital | $21,341 (as of Jan 31, 2011) | |
| Total Debt (Bank Borrowings + Leases) | $4,752 (as of Jan 31, 2011) |
Material Changes vs. Prior Period
- Revenue: Sales for the three months ended Jan 31, 2011, increased 3.5% to $22.6 million compared to the prior year, driven by a 26.6% increase in international sales ($3.46M vs $2.73M). Domestic sales remained flat. For the nine-month period, total sales decreased 2.8% to $73.1 million, as a 34.1% increase in international sales was offset by a 7.2% decline in domestic sales.
- Profitability: Operating earnings declined significantly, dropping 84.7% for the quarter ($156k vs $1.02M) and 48.0% for the nine months ($2.63M vs $5.05M). Net earnings attributable to the Company fell 86.2% for the quarter and 47.5% for the nine months.
- Margins: Gross profit margins compressed to 18.4% (quarter) and 20.0% (nine months) from 21.5% and 22.2% in the prior year, respectively. This was attributed to aggressive pricing, unfavorable product mix, and higher raw material costs (specifically epoxy resin).
- Order Backlog: Increased to $68.2 million at Jan 31, 2011, from $65.5 million at Jan 31, 2010.
Guidance, Outlook, and Risks
- Outlook: Management expects sales and earnings for the fourth quarter of fiscal 2011 to likely improve over the third quarter. This expectation is based on the shipment of orders delayed in the third quarter and an improved product mix.
- Capital Allocation: The Company secured a $4 million seven-year term loan in August 2010 to fund the expansion of its Statesville, North Carolina manufacturing facilities. Capital expenditures for the nine months totaled $4.7 million.
- Liquidity: The Company maintains a current ratio of 2.4-to-1.0. Short-term borrowings under the revolving credit facility decreased to $696,000 from $4.87 million at the prior fiscal year-end.
- Risks: Key risks include customer changes to product designs and delivery dates (which delay revenue recognition and increase costs), softness in the domestic marketplace for small/mid-sized projects, and volatility in raw material prices (petroleum-based epoxy resin).
Investor Verification Checklist
- Margin Compression: Verify the sustainability of gross margins given the cited increase in epoxy resin costs and aggressive pricing strategies.
- Domestic Demand: Assess the trend in domestic sales, which declined 7.2% year-over-year for the nine-month period, contrasting with international growth.
- Order Backlog Conversion: Monitor the conversion of the $68.2 million order backlog into revenue, noting the impact of customer design changes on shipment timing.
- Debt Structure: Review the terms of the new $4 million term loan and the associated interest rate swap (fixed at 4.875%) to understand future interest expense obligations.
- Capital Expenditures: Confirm the progress and ROI of the Statesville facility expansion funded by recent debt proceeds.